The NACDS Pharmacy & Technology Conference offers the most expansive and timely selection of education programming. Topics presented cover the most critical issues facing chain pharmacy today. This is the only industry conference that provides solution-oriented educational programming that will help you run your business better! This year's education session line-up is below. We are continuously updating this schedule, so please check back regularly!
Saturday, August 11, 2007
1:00 p.m. – 4:00 p.m.
The Tenth Annual Forum (by invitation only):
The Annual Forum provides attendees with the opportunity to cultivate strong working relationships with one another, share their ideas and thoughts with their colleagues and peers, and gain up-to-date information from nationally recognized speakers on current issues facing pharmacy. This year's Annual Forum will highlight community pharmacy's role in emergency preparedness including discussions on state emergency management programs, community pharmacist involvement in emergency preparedness, pharmacist educational preparation for emergency preparedness, and electronic records and patient histories to assist pharmacy response to emergencies and disasters.
| Speakers: | Gay Dodson, RPh Craig Fugate Rick Ratliff Gregory Sciarra, RPh Andy Stergachis |
|
Supported by Merck & Co., Inc. |
||
Sunday, August 12, 2007
9:45 a.m. – 10:45 a.m.
Pharmacy Customer Satisfaction: Building Customer Loyalty
Attaining a high level of customer satisfaction is crucial to achieving customer loyalty and business success. Many factors influence a customer's perspective of a pharmacy, such as convenience and store product and service offerings. However, timeliness, knowledge of insurance coverage, adequate supply of medications, and consistently delivering superior professional and customer service keeps customers coming back. This program will present new results from the recent pharmacy customer satisfaction survey that identifies retail customers' perception of their pharmacy, their level of satisfaction, and loyalty to the store they use most often to fill prescriptions. These results can help achieve a better perspective on how to increase customer loyalty and satisfaction, as well as show trends on how perceptions have changed over time. This year's survey also covers all new topics such as member's perceptions of their Medicare Part D PDP and store services such as IVR, Prescription Kiosks, 24-hour customer service numbers, $4.00 generic prescriptions, Price Matching policies, Medication Therapy Management (MTM) Services, automation, compounding and prescription flavoring.
| Speaker: | James M. Wilson, RPh, MBA (Presentation) Wilson Health Information, LLC |
|
Supported by Boehringer Ingelheim Pharmaceuticals, Inc. |
||
9:45 a.m. – 10:45 a.m.
Practice Based Research Networks: A Springboard for Payment of Pharmacy Services
This session will describe practice-based research networks (PBRNs) and their importance to community pharmacy. Medicine and dentistry have benefited greatly from their involvement with PBRNs, and there are significant opportunities that these networks offer for community pharmacy. Find out how community pharmacy and pharmacy academia can partner to advance patient care outcomes and discover ways that PBRNs may drive payment for community pharmacy services.
| Speakers: | Rebecca W. Chater, RPh, MPH, FAPhA (Presentation) Jean-Venable “Kelly” Goode, PharmD (Presentation) |
|
Supported by Mylan Pharmaceuticals Inc. |
||
9:45 a.m. – 10:45 a.m.
Significant Trends Affecting the Pharmacist Shortage
Learn about the latest trends impacting the pharmacist shortage during this session. Recent data from the Aggregate Demand Index and NACDS' manpower survey will be used to interpret the shortage on the national and state levels. This session will also analyze the full-time equivalent (FTE) differential and what it means to the future workforce. The impact of the baby boomer generation will also be discussed. This session will also explore pharmacy school trends, including new schools, applicant rates and types of applicants, and international graduates.
| Speaker: | Katherine Knapp, PhD Touro University - California College of Pharmacy |
|
Supported by Bayer HealthCare Pharmaceuticals |
||
9:45 a.m. – 10:45 a.m.
Pharmacy Quality Alliance Initiatives: Measuring Pharmacy Performance in 2008 and Beyond
The Pharmacy Quality Alliance was established in April 2006, and is centered on developing performance measures for pharmacies and pharmacists. PQA's mission is to improve health care quality and patient safety through a process in which key stakeholders agree on a strategy for measuring performance at the pharmacy and pharmacist-levels; and reporting meaningful information to consumers, pharmacists, employers, payers, and other healthcare decision-makers to help make informed choices, improve outcomes and stimulate the development of new payment models. This session is designed to communicate to the audience what PQA performance measures are; how pharmacies will be evaluated utilizing these measures, and what types of demonstration projects are being pursued with what types of partners.
| Speakers: | Laura J. Cranston, RPh (Presentation) William K. Fleming (Presentation) Kimberly P. McDonough, PharmD (Presentation) |
|
Supported by sanofi-aventis |
||
9:45 a.m. – 11:00 a.m.
Medicaid Reform Update
Major changes in Medicaid pharmacy reimbursement are expected from implementation of the Federal Deficit Reduction Act of 2005. The new law reduced generic drug payments to pharmacies by billions of dollars by changing the way that the Federal Upper Limits for generic drugs is calculated. Manufacturer AMP data for brand and generic drugs – as well as Retail Survey Price (RSP) data - are being made available to the states and the public, creating greater transparency in pharmaceutical pricing. In addition, states will have greater flexibility in setting co-payments for prescription drugs in their Medicaid populations. Representatives from CMS and the states will explain these new changes and the timeline for their implementation. The session will also discuss the impact on community retail pharmacy.
| Speakers: | Deirdre Duzor (Presentation) Paul Jeffrey, PharmD |
|
Supported by Barr Laboratories, Inc. |
||
1:00 p.m. – 3:00 p.m.
Special Session for Educators and Regulators:
Building Strategies and Partnerships for Experiential Education in Community Pharmacies
With an increased emphasis on experiential learning in the ACPE Standards 2007, it is more important than ever that schools and community pharmacies work together to achieve the goals of experiential education. This session will provide an update on the implementation of Standards 2007 with regards to experiential learning. It will also discuss unique approaches to partnerships between schools and community pharmacies, preceptor training and recognition, and curriculum development.
| Speakers: | Philip M. Hritcko, PharmD (Presentation) Eleanor Vogt, RPh, PhD Jeffrey W. Wadelin, PhD (Presentation) Janeen Winnike (Presentation) |
|
Supported by Bristol-Myers Squibb |
||
Monday, August 13, 2007
9:45 a.m. – 10:45 a.m.
Update on the Implementation of the NPI for Pharmacy and NCPDP Standards
This session will include an update on the Implementation of the NPI as it affects the pharmacy industry, which will include information on the dissemination notice and NPPES dissemination files. This session will also include an update on requests that have been brought by CMS such as vaccine billing for Part D claims using the NCPDP Telecommunication Standard Version 5.1. The standards being brought forward under HIPAA for future implementation will also be discussed.
| Speakers: | Lynne Gilbertson (Presentation) Michele Vilaret, RPh (Presentation) |
9:45 a.m. – 10:45 a.m.
Paving the Pathway: Complying With Pedigree Track and Trace Regulations
A growing number of states are looking at increasing an already safe and secure supply chain by requiring the use of electronic pedigrees and track and trace technologies. However, because there is not consistency in approach by states that have already passed legislation, how should a company – or industry plan to comply with these laws? Through EPC global, a standards development group, a roadmap has been defined for various companies in the supply chain to use as they begin to plan how to comply with these various laws and regulations. This session will highlight the major steps companies might consider, from the perspective of a pharmacy, distributor and manufacturer, as they move towards complying with new legislation.
| Speakers: | Grant Hodgkins (Presentation) Peggy Staver (Presentation) |
9:45 a.m. – 10:45 a.m.
Update on the Community Health Centers and the PHS 340B Pharmaceutical Program
Expansion of community health centers remains a key component of the Administration's approach to increasing health care access to uninsured populations. As a result, many community pharmacies may view these centers - and the clinic pharmacies that they operate - as competitors because these clinics generally have access to better pricing than retail pharmacies. However, partnerships with these clinics may present opportunities for retail pharmacies to expand their services to communities and populations that have traditionally been underserved. This session will provide an update on the 340B pharmaceutical pricing program and give retail pharmacies the opportunity to assess new business and patient care opportunities through partnerships with 340B entities.
| Speakers: | Jimmy R. Mitchell, RPh, MPH, MS (Presentation) William H. von Oehsen, JD (Presentation) |
9:45 a.m. – 10:45 a.m.
Update on the Specialty Pharmacy Pipeline and the Future of Biosimilars
New specialty drugs are improving health outcomes and quality of life for many patients, but at what cost to the healthcare system. This session will identify the top specialty drugs in the pipeline and the potential impact of biosimilars on the specialty pipeline. The current status of the legal/regulatory landscape of biosimilars will also be discussed.
| Speakers: | Jeremy B. Desai, PhD (Presentation) Richard J. Faris, PhD, RPh (Presentation) |
9:45 a.m. – 11:00 a.m.
Update on Medicare Part D: 2008 and Beyond
The new Medicare Part D prescription drug benefit program is now in its second year of existence, and appears to be helping millions of seniors pay for their prescription medications. Pharmacists and beneficiaries continue to work through several challenging issues with the program's implementation. Ongoing policy and implementation challenges must be addressed to assure the continued viability of the program. In this session, representatives from CMS and health plans will focus on current Part D implementation issues and provide insight into what beneficiaries and pharmacists may expect from Medicare Part D in 2008.
| Speaker: | Thomas S. Paul (Presentation) Adele Pietrantoni, BSPharm, FAPhA |
|
| Supported by Abbott Laboratories Inc. – Pharmaceutical Products Division | ||
11:00 a.m. – 12:00 noon
Personal Health Records: Pharmacy Roles and Direct Benefits
Personal Health Records (PHRs) are getting national attention as a means of directly engaging consumers to improve care quality, convenience and cost-efficiency. Employers, government and payers are pushing for online patient engagement through PHRs, but patients are looking for a local connection to their own providers. This session will discuss the details of the national drivers for PHRs, successes and failures of PHR efforts in the market and the opportunities for pharmacies to take a leadership role in PHR delivery, patient engagement and data updates of PHRs.
| Speaker: | Robert Burg Medem, Inc. |
|
Supported by Upsher-Smith Laboratories, Inc. |
||
11:00 a.m. – 12:00 noon
Medicare Part B: Competitive Bidding for DME
Products and services provided under Medicare Part B continue to be an important part of the average retail pharmacy's business. However, CMS is embarking on a new program that would require Part B suppliers to competitively bid to provide certain items of durable medical equipment (DME) in 2007, limiting the number of suppliers that might be able to provide these products. This could eventually affect the ability of pharmacy providers to supply Medicare DME items to beneficiaries. Suppliers will also have to attain accreditation by meeting new CMS quality and business standards. This session will focus on what retail pharmacy operators need to know about changes to the Medicare Part B program for DME and how to retain this part of that business.
| Speaker: | Adele Pietrantoni, BSPharm, FAPhA Timothy P. Trysla, JD |
|
Supported by Roche Diagnostics |
||
11:00 a.m. – 12:00 noon
FDA Issues Update
The program will address current FDA initiatives and actions that affect the practice of pharmacy. Topics to be addressed include drug safety, Medication Guides and other patient information, prescription drug pedigrees and RFID, drug importation, generic substitution, compounding, drug approvals, and other recent activities. Third class of drugs will also be discussed.
| Speaker: | Arthur Tsien, JD (Presentation) Olsson, Frank and Weeda, P.C. |
|
Supported by Eli Lilly and Company |
||
11:00 a.m. – 12:00 noon
Quality Improvement Organizations and Community Pharmacy: Partnering to Improve Quality Pharmacy Care
Quality Improvement Organizations (QIOs) provide tools, resources and complimentary assistance to healthcare providers to improve the quality of patient care. This program will describe the activities, responsibilities and a brief history of QIOs as well as their role in partnering with prescription drug plans to improve the safe use of prescription drugs. This session will also include how QIOs are currently working with prescription drug plans and pharmacies and how pharmacies and QIOs can partner in the future to improve patient safety and use of prescription medications.
| Speakers: | Julie Kuhle, RPh (Presentation) Darren Triller, PharmD (Presentation) |
11:00 a.m. – 12:00 noon
Patient Safety in Community Pharmacy
Health care consumers entrust the nation's community pharmacists to provide over 3 billion prescriptions a year. Fortunately, harmful dispensing errors represent an extreme minority, given all the prescription medications safely dispensed each year. Nevertheless, a study of 50 community pharmacies revealed a 1.7% dispensing error rate overall and harmful events have frequently been the subject of alarming reports by local and national news media. The problem clearly warrants more attention from the patient safety community. This session brings together a panel of experts familiar with community pharmacy patient safety issues, including a patient safety officer from a large chain pharmacy, a safety officer from one of the largest pharmacy benefits management firms, and a director of pharmacy from the payer community to discuss this important issue.
| Speakers: | Mary Burkhardt, RPh, MS, FASHP Michael R. Cohen, RPh, MS, ScD Thomas P. Lawlor, RPh Mark Rubino, RPh, MHA |
|
Supported by TEVA Pharmaceuticals |
||
Tuesday, August 14, 2007
8:00 a.m. – 10:00 a.m.
Pharmaceutical Trends, Issues and Forecasts
Get an expert's view of the 2007 pharmaceuticals market, highlighting trends, issues and forecasts in demographics, sales, markets and more. Find out which industry segments are growing or declining, and how evolving trends may impact you and your business.
| Speaker: | Douglas M. Long IMS HEALTH |
|
Supported by Novo Nordisk Inc. |
||
8:00 a.m. – 10:00 a.m.
Meeting Payer Needs for Pharmacist Provided Services: The Time is Now
Solid evidence for the value of pharmacists in improving patient outcomes and reducing overall health care costs exists in some settings, e.g., integrated delivery systems, hospitals, and the VA. But payers point out that such compelling data is lacking for the community setting. The NACDS Pharmacy Industry Council (PIC) Value of Pharmacy Committee has been working with Comstock Consulting Group (CCG) on a collaborative project to produce a “roadmap” for community pharmacy to help the industry better understand how to transition to a broader role in the healthcare delivery system, demonstrate its' value, and get paid for its' capabilities. This session will draw on the project findings, highlighting the perspectives of both public and private payers. It will engage the audience in a discussion of the challenges faced by the industry in achieving recognition by payers, patients and providers, and payment for medical management services.
| Speakers: | Richard J. Bringewatt Marcia L. Comstock, MD, MPH Brian Sweet M. Christine Whipple |
|
Supported by Ortho-McNeil Janssen Pharmaceutical Services |
||
10:15 a.m. – 11:15 a.m.
Pharmacy Law and Regulatory Update
This session will provide an update on pharmacy practice issues important to chain pharmacy operators. The discussion will focus on trends in federal and state laws and regulations in the realm of Pharmacy Practice, Methamphetamine Precursor sales restrictions, Controlled Substances, Dextromethorphan sales restrictions, and other topical issues affecting pharmacy practice.
| Speaker: | Debbie B. Garza, RPh (Presentation) Walgreen Co. |
|
Supported by Apotex Corp. |
||
10:15 a.m. – 11:15 a.m.
Pandemic Preparedness for Chain Community Pharmacies
A pandemic situation is a significant threat to a region. While no one can predict exactly if or when an outbreak will occur, community pharmacies must be proactive and act now to ensure readiness. This session will focus on the latest pandemic information and the significance of building a plan to serve the community in the event of an outbreak. Community pharmacy's role in monitoring and reporting to authorities during a pandemic situation will be also be discussed, as well as ways to meet your company's own operating needs during a pandemic situation.
| Speaker: | Stuart B. Weiss, MD, FAAP, FACEP (Presentation) MedPrep Consulting Group, LLC |
|
Supported by Roche Laboratories, Inc. |
||
10:15 a.m. – 11:15 a.m.
Wall Street's View of Retail Pharmacy
This session will include a Wall Street analyst's view of current retail pharmacy trends, as well as insight on current issues impacting the industry such as retail clinics, AMP, Medicare Part D, RFID, and specialty pharmacy. Investors' views of primary success factors for retail drug stores and the outlook for retail drug chains will also be discussed.
| Speaker: | Karen Howland (Presentation) |
|
Supported by Catalina Health Resource |
||
10:15 a.m. – 11:15 a.m.
CMS Update: The Status of MTM Services in Medicare Part D Plans
As Medication Therapy Management (MTM) services become more widespread in community pharmacy practice, it's important for the industry to understand from the CMS perspective how MTM is defined, how it's being implemented, and future opportunities surrounding MTM. CMS regulations and requirements for MTM programs will be discussed, as well as a historical overview of MTM since its inception and characteristics of MTM programs for 2007.
| Speaker: | Michelle Ketcham, PharmD, MBA (Presentation) |
10:15 a.m. – 11:45 a.m.
Chain Member and DME MAC Interactive Forum
This session will allow chain pharmacy retailers to better understand the many changes in the requirements relating to coverage and participation in the Medicare Part B program, and how they impact the provision of products and services to Medicare beneficiaries. Representatives from the Durable Medical Equipment Medicare Administrative Carriers (DME MACs) and the National Supplier Clearinghouse (NSC) will be asked to participate. Topics will include Part B billing and supplying issues, changes in structure of the DMERCs (now known as DME MACs) and the recently published rule for the competitive bidding of DME.
| Speakers: | Brian Banks Elizabeth Daniels Nina Gregory James K. Hardiman Christy Harwood Janet Kirsch Charles R. Oltman, MBA Sonja Racke Joy Stopher |
Wednesday, August 15, 2007
8:00 a.m. – 9:00 a.m.
MTM: A Chain Pharmacy Success Story
In 2006, Outcomes Pharmaceutical Health Care began working with AvMed Health Plans to implement a Medication Therapy Management (MTM) program for a Medicare population based in southern Florida. The MTM program, which continues into 2007, covers all approximately 20,000 AvMed Medicare Advantage Prescription Drug Plan members and is focused entirely on face-to-face services provided by local pharmacists. Winn-Dixie pharmacies have been active participants in the AvMed program and other MTM opportunities while finding innovative solutions to implementation challenges. This session explores the relationship between a chain pharmacy organization, a Medicare plan sponsor, and an MTM administration firm. It will also focus on the successes and challenges of Medicare Part D MTM 18-plus months after launch.
| Speakers: | Brand Newland, PharmD (Presentation) Teresa Roane, PharmD Daniel Rodriguez, RPh |
9:15 a.m. – 10:15 a.m.
Retail Health Clinics: What Does the Future Hold?
Since they came onto the scene a few years ago, retail-based health clinics have attracted a lot of attention from the media, the public, the medical establishment, investors and retailers. These clinics have proliferated rapidly, and consumers across all socioeconomic groups are increasing their use of clinics and reporting high levels of satisfaction. This session will focus on the retailer strategies for these clinics, different retailer models for partnering with retail clinic operators, and the impact on the pharmacy, OTC, and retail business.
| Speaker: | Mary Kate (Presentation) Scott Scott & Company, Inc. |
|